0001004878-15-000198.txt : 20150623 0001004878-15-000198.hdr.sgml : 20150623 20150623110645 ACCESSION NUMBER: 0001004878-15-000198 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150622 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20150623 DATE AS OF CHANGE: 20150623 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11889 FILM NUMBER: 15946397 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 8-K 1 form8kitem507annmting6-15.txt FORM 8-K ITEM 5.07 ANNUAL MEETING UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): June 22, 2015 CEL-SCI CORPORATION -------------------------------------- (Exact name of Registrant as specified in its charter) Colorado 0-11503 84-091634 -------------------- ------------------ ---------------- (State or other jurisdiction (Commission File No.) (IRS Employer of incorporation) Identification No.) 8229 Boone Boulevard, Suite 802 Vienna, Virginia 22182 --------------------------------------------------- (Address of principal executive offices, including Zip Code) Registrant's telephone number, including area code: (703) 506-9460 N/A ---------------------------------------------------- (Former name or former address if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions: [ ] Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-14c)) Item 5.07. Submission of Matters to a Vote of Securities Holders. The annual meeting of CEL-SCI's shareholders was held on June 22, 2015. At the meeting the following persons were elected as directors for the upcoming year: Votes ------------------------ Broker Name For Against Non-Votes ---- --- ------- --------- Maximilian de Clara 24,855,097 1,674,328 40,338,668 Geert R. Kersten 25,576,797 952,628 40,338,668 Alexander G. Esterhazy 22,833,534 3,695,891 40,338,668 Peter R. Young 23,030,286 3,499,139 40,338,668 Bruno Baillavoine 25,783,505 745,920 40,338,668 At the meeting the following were ratified by CEL-SCI's shareholders: (1) the adoption of CEL-SCI's 2015 Non-Qualified Stock Option Plan; (2) the adoption of CEL-SCI's 2015 Stock Bonus Plan; (3) the adoption of CEL-SCI's 2015 Stock Compensation Plan; (4) the extension of CEL-SCI's Shareholder Rights Plan; and (5) ratification of the appointment of BDO USA, LLP as CEL-SCI's independent registered public accounting firm for the fiscal year ending September 30, 2015; The following is a tabulation of votes cast with respect to proposals 1, 2, 3, 4 and 5: Votes ---------------------------------- Broker Proposal For Against Abstain Non-Votes -------- --- ------- ------- --------- (1) 20,734,651 5,331,348 463,426 40,338,668 (2) 23,126,729 2,950,765 451,931 40,338,668 (3) 23,215,664 2,868,086 445,675 40,338,668 (4) 22,560,712 3,757,778 210,935 40,338,668 (5) 65,004,137 1,172,789 691,167 0 2 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: June 23, 2015 CEL-SCI CORPORATION By: /s/ Patricia B. Prichep -------------------------------- Patricia B. Prichep Senior Vice President of Operations